In our cohort, the combined prevalence of cardiogenic shock and cardiorenal syndrome exceeds one-third, marking a substantial portion of patients at an increased risk of these acute complications
Legally, GLP-1 medications are prescription-only in Mexico
These early insights from the COURAGE trialclearly establish the principle that blocking GDF8 with or without activin A can preserve muscle and further increase fat loss in patients being treated with GLP-1 therapy, thereby improving the quality of weight loss, said George Yancopoulos, president and chief scientific officer at Regeneron, in a statement from the company
The chronic inflammatory environment degrades existing collagen faster than the body can replace it, and the disorganized keratinocyte proliferation further disrupts normal tissue structure
The drug remains in active clinical development, with Phase 3 trials currently underway evaluating retatrutide's efficacy and safety across broader populations, including individuals with obesity, type 2 diabetes, and cardiovascular disease